<DOC>
	<DOCNO>NCT02041624</DOCNO>
	<brief_summary>The purpose present study describe patient 's perception quality life effectiveness ORALAIR速 follow-up period 5 year , real-life setting .</brief_summary>
	<brief_title>International Registry Quality Life Patients With Grass-pollen-induced Allergic Rhinitis</brief_title>
	<detailed_description>Primary objective : To describe patient 's perception impact ORALAIR速 his/her health relate generic disease specific quality life grass pollen season real-life setting . Secondary objective : - To describe patient 's perceived effectiveness ORALAIR速 allergic rhinoconjunctivitis management term disease intensity , satisfaction rescue medication</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Patient 5 year age old date screen visit Patient proven allergic rhinoconjunctivitis due grass pollen Patient eligible grasspollen Allergen ImmunoTherapy ( AIT ) Patient whose physician prescribe ORALAIR速 independently study , begin grasspollen season Patient participate clinical trial epidemiological study</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>allergic</keyword>
	<keyword>rhinitis</keyword>
	<keyword>conjunctivitis</keyword>
	<keyword>grass pollen</keyword>
	<keyword>Allergen ImmunoTherapy ( AIT )</keyword>
	<keyword>grass mix</keyword>
</DOC>